192 related articles for article (PubMed ID: 30083881)
1. A novel germline mutation at exon 10 of MEN1 gene: a clinical survey and positive genotype-phenotype analysis of a MEN1 Italian family, including monozygotic twins.
Palermo A; Capoluongo E; Del Toro R; Manfrini S; Pozzilli P; Maggi D; Defeudis G; Pantano F; Coppola R; Di Matteo FM; Raffaelli M; Concolino P; Falchetti A
Hormones (Athens); 2018 Sep; 17(3):427-435. PubMed ID: 30083881
[TBL] [Abstract][Full Text] [Related]
2. Natural History of MEN1 GEP-NET: Single-Center Experience After a Long Follow-Up.
Giudici F; Cavalli T; Giusti F; Gronchi G; Batignani G; Tonelli F; Brandi ML
World J Surg; 2017 Sep; 41(9):2312-2323. PubMed ID: 28429092
[TBL] [Abstract][Full Text] [Related]
3. Multiple endocrine neoplasia type 1: extensive analysis of a large database of Florentine patients.
Marini F; Giusti F; Brandi ML
Orphanet J Rare Dis; 2018 Nov; 13(1):205. PubMed ID: 30428914
[TBL] [Abstract][Full Text] [Related]
4. c-MET inhibition: novel treatment for sporadic and MEN1-associated GEP NETs.
Lee ME; Tepede AA; Mandl A; Weinstein LS; Del Rivero J; Agarwal SK; Blau JE
J Mol Endocrinol; 2020 Aug; 65(2):R1-R17. PubMed ID: 32384260
[TBL] [Abstract][Full Text] [Related]
5. Multiple endocrine neoplasia type 1: analysis of germline MEN1 mutations in the Italian multicenter MEN1 patient database.
Marini F; Giusti F; Fossi C; Cioppi F; Cianferotti L; Masi L; Boaretto F; Zovato S; Cetani F; Colao A; Davì MV; Faggiano A; Fanciulli G; Ferolla P; Ferone D; Loli P; Mantero F; Marcocci C; Opocher G; Beck-Peccoz P; Persani L; Scillitani A; Guizzardi F; Spada A; Tomassetti P; Tonelli F; Brandi ML
Endocrine; 2018 Oct; 62(1):215-233. PubMed ID: 29497973
[TBL] [Abstract][Full Text] [Related]
6. Phenotypes Associated With MEN1 Syndrome: A Focus on Genotype-Phenotype Correlations.
Mele C; Mencarelli M; Caputo M; Mai S; Pagano L; Aimaretti G; Scacchi M; Falchetti A; Marzullo P
Front Endocrinol (Lausanne); 2020; 11():591501. PubMed ID: 33312161
[TBL] [Abstract][Full Text] [Related]
7. Genotype/phenotype correlation of multiple endocrine neoplasia type 1 gene mutations in sporadic gastrinomas.
Goebel SU; Heppner C; Burns AL; Marx SJ; Spiegel AM; Zhuang Z; Lubensky IA; Gibril F; Jensen RT; Serrano J
J Clin Endocrinol Metab; 2000 Jan; 85(1):116-23. PubMed ID: 10634374
[TBL] [Abstract][Full Text] [Related]
8. Multiple endocrine neoplasia type 1 in Poland: a two-centre experience.
Soczomski P; Jurecka-Lubieniecka B; Rogozik N; Tukiendorf A; Jarząb B; Bednarczuk T
Endokrynol Pol; 2019; 70(5):385-391. PubMed ID: 31274185
[TBL] [Abstract][Full Text] [Related]
9. A germline c.1546dupC MEN1 mutation in an MEN1 family: A case report.
Cho YY; Chung YJ
Medicine (Baltimore); 2021 Jun; 100(25):e26382. PubMed ID: 34160414
[TBL] [Abstract][Full Text] [Related]
10. Identification of the BRAF V600E mutation in gastroenteropancreatic neuroendocrine tumors.
Park C; Ha SY; Kim ST; Kim HC; Heo JS; Park YS; Lauwers G; Lee J; Kim KM
Oncotarget; 2016 Jan; 7(4):4024-35. PubMed ID: 26684240
[TBL] [Abstract][Full Text] [Related]
11. Current status of Interventional Radiology in the management of Gastro-Entero-Pancreatic Neuroendocrine Tumours (GEP-NETs).
Orgera G; Krokidis M; Cappucci M; Gourtsoyianni S; Tipaldi MA; Hatzidakis A; Rebonato A; Rossi M
Cardiovasc Intervent Radiol; 2015 Feb; 38(1):13-24. PubMed ID: 25366087
[TBL] [Abstract][Full Text] [Related]
12. Indications for genetic study in gastro-entero-pancreatic and thoracic neuroendocrine tumors.
Araujo-Castro M
Endocrinol Diabetes Nutr (Engl Ed); 2023 Mar; 70 Suppl 1():63-73. PubMed ID: 36396595
[TBL] [Abstract][Full Text] [Related]
13. Clinical application of microRNA testing in neuroendocrine tumors of the gastrointestinal tract.
Vicentini C; Fassan M; D'Angelo E; Corbo V; Silvestris N; Nuovo GJ; Scarpa A
Molecules; 2014 Feb; 19(2):2458-68. PubMed ID: 24566314
[TBL] [Abstract][Full Text] [Related]
14. Penetrance of functioning and nonfunctioning pancreatic neuroendocrine tumors in multiple endocrine neoplasia type 1 in the second decade of life.
Gonçalves TD; Toledo RA; Sekiya T; Matuguma SE; Maluf Filho F; Rocha MS; Siqueira SA; Glezer A; Bronstein MD; Pereira MA; Jureidini R; Bacchella T; Machado MC; Toledo SP; Lourenço DM
J Clin Endocrinol Metab; 2014 Jan; 99(1):E89-96. PubMed ID: 24178797
[TBL] [Abstract][Full Text] [Related]
15. Secretin Stimulation Test and Early Diagnosis of Gastrinoma in MEN1 Syndrome: Survey on the MEN1 Florentine Database.
Giusti F; Cioppi F; Fossi C; Marini F; Masi L; Tonelli F; Brandi ML
J Clin Endocrinol Metab; 2022 Apr; 107(5):e2110-e2123. PubMed ID: 34922358
[TBL] [Abstract][Full Text] [Related]
16. True MEN1 or phenocopy? Evidence for geno-phenotypic correlations in MEN1 syndrome.
Kövesdi A; Tóth M; Butz H; Szücs N; Sármán B; Pusztai P; Tőke J; Reismann P; Fáklya M; Tóth G; Somogyi A; Borka K; Erdei A; Nagy EV; Deák V; Valkusz Z; Igaz P; Patócs A; Grolmusz VK
Endocrine; 2019 Aug; 65(2):451-459. PubMed ID: 31044390
[TBL] [Abstract][Full Text] [Related]
17. Aberrant Expression of Long Non Coding RNA HOTAIR and De-Regulation of the Paralogous 13 HOX Genes Are Strongly Associated with Aggressive Behavior of Gastro-Entero-Pancreatic Neuroendocrine Tumors.
Di Mauro A; Scognamiglio G; Aquino G; Cerrone M; Liguori G; Clemente O; Di Bonito M; Cantile M; Botti G; Tafuto S; Tatangelo F
Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34208964
[TBL] [Abstract][Full Text] [Related]
18. Plasma chromogranin A in patients with sporadic gastro-entero-pancreatic neuroendocrine tumors or multiple endocrine neoplasia type 1.
Peracchi M; Conte D; Gebbia C; Penati C; Pizzinelli S; Arosio M; Corbetta S; Spada A
Eur J Endocrinol; 2003 Jan; 148(1):39-43. PubMed ID: 12534356
[TBL] [Abstract][Full Text] [Related]
19. A novel deletion of the MEN1 gene in a large family of multiple endocrine neoplasia type 1 (MEN1) with aggressive phenotype.
Raef H; Zou M; Baitei EY; Al-Rijjal RA; Kaya N; Al-Hamed M; Monies D; Abu-Dheim NN; Al-Hindi H; Al-Ghamdi MH; Meyer BF; Shi Y
Clin Endocrinol (Oxf); 2011 Dec; 75(6):791-800. PubMed ID: 21627674
[TBL] [Abstract][Full Text] [Related]
20. Higher risk of aggressive pancreatic neuroendocrine tumors in MEN1 patients with MEN1 mutations affecting the CHES1 interacting MENIN domain.
Bartsch DK; Slater EP; Albers M; Knoop R; Chaloupka B; Lopez CL; Fendrich V; Kann PH; Waldmann J
J Clin Endocrinol Metab; 2014 Nov; 99(11):E2387-91. PubMed ID: 25210877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
